Gutwerg Ori
SVP, GENERICS
Gutwerg Ori has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, Gutwerg Ori is listed as SVP, GENERICS at ANI PHARMACEUTICALS INC. Inside the rolling window, Gutwerg Ori reported no open-market purchases and 3 open-market sales totaling $621K in ANIP. The largest disclosed transaction in the window is a sale of 3,162 ANIP shares on Aug 10, 2026, worth $243K.
Companies traded
Other insiders at ANIP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$621K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gutwerg Ori made?
Gutwerg Ori has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Gutwerg Ori trade?
Gutwerg Ori has filed SEC Form 4 disclosures for 1 company, including ANIP.
When was Gutwerg Ori's most recent SEC Form 4 filing?
Gutwerg Ori's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is Gutwerg Ori's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gutwerg Ori is listed as SVP, GENERICS.
What is Gutwerg Ori's total buy and sell value in the current window?
Inside the rolling retention window, Gutwerg Ori bought $0 and sold $621K based on SEC Form 4 filings.
What was Gutwerg Ori's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,162 ANIP shares on 2026-08-10, worth $243K, per SEC Form 4 filings.